Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales153 290177 526184 765188 918196 488203 911
EBITDA11 90813 05312 65312 52612 89513 412
Operating profit (EBIT)10 42711 3739 9879 96010 24210 705
Pre-Tax Profit (EBT)------
Net income5 2375 3176 6225 3316 5236 672
P/E ratio21,116,111,314,010,910,4
EPS ( $ )4,634,906,445,116,576,91
Dividend per Share ( $ )1,401,702,002,112,362,58
Yield1,43%2,15%2,76%2,94%3,30%3,60%
Reference price ( $ )97.7778.9172.571.671.671.6
Announcement Date02/09/2016
11:51am
02/09/2017
11:55am
02/08/2018
11:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt24 91724 07325 19519 67816 52912 287
Finance------
Operating income (EBITDA)11 90813 05312 65312 52612 89513 412
Leverage
(Debt/EBITDA)
2,09x1,84x1,99x1,57x1,28x0,92x
Capital Expenditure2 3672 2241 9182 0712 1642 345
Book Value Per Share (BVPS)33,8 $34,7 $37,1 $40,9 $43,5 $46,3 $
Cash Flow per Share7,47 $9,33 $7,82 $9,28 $9,48 $10,2 $
Announcement Date02/09/2016
11:51am
02/09/2017
11:55am
02/08/2018
11:55am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 71 948 M$ -
Entreprise Value (EV) 91 626 M$ 88 477 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 14,0x 10,9x
Capitalization / Revenue 0,38x 0,37x
EV / Revenue 0,49x 0,45x
EV / EBITDA 7,32x 6,86x
Yield (DPS / Price) 2,94% 3,30%
Price to book (Price / BVPS) 1,75x 1,65x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 5,27% 5,21%
operating Leverage (Delta EBIT / Delta Sales) - 0,71x
Net Margin (Net Profit / Revenue) 2,82% 3,32%
ROA (Net Profit / Asset) 5,88% 5,90%
ROE (Net Profit / Equities) 15,9% 15,8%
Rate of Dividend 41,2% 35,9%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   1,10% 1,10%
Cash Flow / Sales 4,99% 4,91%
Capital Intensity (Assets / Sales) 0,48x 0,56x
Financial Leverage (Net Debt / EBITDA) 1,57x 1,28x
EPS & Dividend